Octreotide Teva 20


Prolonged release suspension for injection
scheduling status
S4
registration number
54/34/0426
What Octreotide Teva 20 contains
Octreotide 20 mg (as octreotide acetate).
other ingredients
Powder (microspheres): D,L-lactide/glycolide copolymer 55/45 and mannitol Suspension vehicle: carmellose sodium, mannitol, poloxamer 188 and water for injections.
Therapeutic classification
H01C B02 - somatostatin and analogues.
© 2026 SAHPRA. ALL RIGHTS RESERVED